Search research articles
Contact Us
Filters
Showing results (431-440 of 545) with videos related to
Page
of 55
Sort By:
Glycobiology
|
February 20, 2019
The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines
Matthew P Campbell, Jodie L Abrahams, Erdmann Rapp, et al.
Molecular Immunology
|
November 21, 2007
Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma
Katy J McCann, Christian H Ottensmeier, Alice Callard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
Peter W Szlosarek, Astero Klabatsa, Arben Pallaska, et al.
British Journal of Cancer
|
June 1, 1996
A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial
L E James, N H Gower, R M Rudd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
D W Miles, O Fogarty, C M Ash, et al.
Chemistry & Biology
|
November 26, 2002
Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor
Zohreh Hojati, Claire Milne, Barbara Harvey, et al.
Journal of Proteome Research
|
December 24, 2013
N-glycan abnormalities in children with galactosemia
Karen P Coss, Colin P Hawkes, Barbara Adamczyk, et al.
Tissue Antigens
|
February 26, 2005
Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis
B Jorgensen-Tye, J-P Levesque, L Royle, et al.
Advances in Experimental Medicine and Biology
|
January 13, 2004
The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12
Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.
British Journal of Cancer
|
September 1, 1991
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial
H M Earl, R M Rudd, S G Spiro, et al.
Page
of 55
Search research articles
Search
Showing results (431-440 of 545) with videos related to
Sort By:
Page
of 55
Glycobiology
|
February 20, 2019
The minimum information required for a glycomics experiment (MIRAGE) project: LC guidelines
Matthew P Campbell, Jodie L Abrahams, Erdmann Rapp, et al.
Molecular Immunology
|
November 21, 2007
Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma
Katy J McCann, Christian H Ottensmeier, Alice Callard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion
Peter W Szlosarek, Astero Klabatsa, Arben Pallaska, et al.
British Journal of Cancer
|
June 1, 1996
A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial
L E James, N H Gower, R M Rudd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1994
Received dose-intensity: a randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
D W Miles, O Fogarty, C M Ash, et al.
Chemistry & Biology
|
November 26, 2002
Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor
Zohreh Hojati, Claire Milne, Barbara Harvey, et al.
Journal of Proteome Research
|
December 24, 2013
N-glycan abnormalities in children with galactosemia
Karen P Coss, Colin P Hawkes, Barbara Adamczyk, et al.
Tissue Antigens
|
February 26, 2005
Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis
B Jorgensen-Tye, J-P Levesque, L Royle, et al.
Advances in Experimental Medicine and Biology
|
January 13, 2004
The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12
Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.
British Journal of Cancer
|
September 1, 1991
A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial
H M Earl, R M Rudd, S G Spiro, et al.
Page
of 55